This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox.
Labor Day is almost here, which means the sprint to the end of 2024 is upon us.
If you’re reading this late-August newsletter from the beach, the pool, or the mountains, I thank you for it. But when you’re done, put down your phone.
Tel Aviv, Israel/Vancouver, Canada, July 11, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “Company”), a biotech company
A University of Arizona Cancer Center researcher was awarded a $1.3 million grant from the National Cancer Institute to study the effectiveness of lifestyle interventions
One out of 100 people will experience a psychotic episode in their lifetime, and these usually appear in late adolescence or early adulthood.
